Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC71181 structure
    GC71181Glucocorticoid receptor modulator 1
    CAS: 2868357-11-1
    纯度: >99.00%

    Glucocorticoid receptor modulator 1是一种口服活性非甾体选择性糖皮质激素受体调节剂,对NF-κB和AP-1的IC50值分别为9 nM和130 nM。

  • GC71186 structure
    GC71186STING-IN-4
    CAS: 2250374-27-5
    纯度: >99.00%

    STING-IN-4(化合物1)是一种STING抑制剂,可抑制STING表达,从而减少STING和核因子-κB(NF-κB)信号传导的激活。

  • GC71189 structure
    GC71189STING-IN-5
    CAS: 2920064-17-9
    纯度: 不显示

    STING-IN-5是一种强效的STING抑制剂,抑制LPS诱导的巨噬细胞中NO的合成,IC50值为1.15μM。

  • GC71215 structure
    GC71215TLR7 agonist 6
    CAS: 2380231-86-5
    纯度: >98.00%

    TLR7 agonist 6(化合物IIb-19)是一种TLR7激动剂,EC50值为1.0 nM。

  • GC71229 structure
    GC71229BMS905
    CAS: 2205846-49-5
    纯度: >99.00%

    BMS905是一种口服活性TLR7和TLR8双抑制剂(ic50分别为0.7和3.2 nM)。

  • GC71230 structure
    GC71230NLRP3-IN-17
    CAS: 2254432-75-0
    纯度: >99.00%

    NLRP3-IN-17是一种有效的、选择性的、口服活性的NLRP3炎性小体抑制剂,IC50值为7 nM。

  • GC71232 structure
    GC71232I-152
    CAS: 311343-11-0
    纯度: >98.00%

    I-152是含有n -乙酰半胱氨酸(NAC)和半胱胺(MEA)的缀合物。

  • GC71258 structure
    GC71258ASK1-IN-4
    CAS: 1427538-26-8
    纯度: 不显示

    ASK1-IN-4(化合物17)是ASK1抑制剂(IC50=0.2μM)。

  • GC71259 structure
    GC71259NH2-C6-ARC186 sodium
    纯度: >92.00%

    NH2-C6-ARC186 sodium是一种含有NH2-C6的改性ARC186,可以偶联到其他肽或分子。

  • GC71273 structure
    GC71273C12-TLRa
    纯度: >99.00%

    C12-TLRa是一种辅助类脂。

  • GC71351 structure
    GC71351HMGB1-IN-1
    纯度: >95.00%

    HMGB1-IN-1(化合物6)在RAW264.7细胞中显示出强烈的NO抑制作用,IC50值为15.9±0.6μM。

  • GC71353 structure
    GC71353VU534
    CAS: 923509-20-0
    纯度: >98.00%

    VU534是一种NAPE-PLD活化剂,EC50为0.30 μM。

  • GC71396 structure
    GC71396Usnoflast
    CAS: 2455519-86-3
    纯度: >98.00%

    Usnoflast是NLRP3调节剂以及非甾体抗炎药(NSAD)。

  • GC71405 structure
    GC71405ADS032
    CAS: 2757333-37-0
    纯度: >99.50%

    ADS032是NLRP1和NLRP3的双重抑制剂,可以快速、可逆和稳定地抑制炎性小体的形成。

  • GC71433 structure
    GC71433Anti-inflammatory agent 70
    纯度: 97.00%

    Anti-inflammatory agent 70(N-Me-SP23)是一种STING蛋白降解剂,抑制STING信号通路。

  • GC71470 structure
    GC71470cGAS-IN-2
    CAS: 2765273-11-6
    纯度: 不显示

    cGAS-IN-2(化合物109)是环GMP-AMP合酶(cGAS)的强效抑制剂,对h-cGAS的IC50为0.01512μM。

  • GC71474 structure
    GC71474NSC80734
    CAS: 501950-47-6
    纯度: 不显示

    NSC80734是一种IL-18抑制剂。

  • GC71480 structure
    GC71480Drpitor1a
    CAS: 73326-98-4
    纯度: 不显示

    Drpitor1a是一种强效的Drp1抑制剂。

  • GC71499 structure
    GC71499NP3-562
    CAS: 2409825-32-5
    纯度: 不显示

    NP3-562是一种强效的、口服活性的三环NLRP3抑制剂,IC50为214 nM。

  • GC71507 structure
    GC715075'-Methylthioadenosine-13C6
    CAS: 2421187-73-5
    纯度: 不显示

    5'-Methylthioadenosine-13C6是13C标记的5'-甲硫腺苷。

  • GC71544 structure
    GC71544Antroquinonol
    CAS: 1010081-09-0
    纯度: >98.00%

    Antroquinonol((+)-Antroquinonol),一种从蘑菇Antrodia camphorata中提取的泛醌衍生物,具有保肝、抗炎和抗癌作用。

  • GC71607 structure
    GC71607Melatonin-d7
    CAS: 615251-68-8
    纯度: >98.00%

    Melatonin-d7是氘标记的褪黑素。

  • GC71617 structure
    GC71617L-Ascorbic acid-13C-2
    CAS: 1313730-17-4
    纯度: >95.00%

    L-Ascorbic acid-13C-2是13C标记的L-抗坏血酸。

  • GC71622 structure
    GC71622Prednisone-d8
    纯度: 不显示

    Prednisone-d8是氘标记的泼尼松。